Bradmer Pharmaceuticals Inc.: Director Resignation

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 07/31/13 -- Bradmer Pharmaceuticals Inc. (the "Corporation") (TSX VENTURE: BMR.H) announced today that Perry N. Dellelce has resigned as a director of the Corporation. He will continue to act as a consultant to the Corporation. The Corporation thanks Mr. Dellelce for his commitment and significant past contribution to the Corporation.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.



Contacts:
Bradmer Pharmaceuticals Inc.
Paul Van Damme
Chief Financial Officer
416.847.6905

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 31.07.2013 - 21:00 Uhr
Sprache: Deutsch
News-ID 283641
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, ONTARIO

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 233 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Bradmer Pharmaceuticals Inc.: Director Resignation"
steht unter der journalistisch-redaktionellen Verantwortung von

Bradmer Pharmaceuticals Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Bradmer Announces Third Quarter 2017 Financial and Operational Results ...

TORONTO, ONTARIO -- (Marketwired) -- 11/06/17 -- Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Company") today announced its third quarter 2017 financial results.Financial ResultsAmounts in US dollars, unless spec ...

Bradmer Announces Second Quarter 2017 Financial Results ...

TORONTO, ONTARIO -- (Marketwired) -- 08/01/17 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (NEX: BMR.H) today announced its second quarter 2017 financial results.Financial ResultsAmounts in US dollars, unless spe ...

Bradmer Announces First Quarter 2017 Financial Results ...

TORONTO, ONTARIO -- (Marketwired) -- 05/15/17 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (NEX: BMR.H) today announced its first quarter 2017 financial results.Financial ResultsAmounts in US dollars, unless spec ...

Alle Meldungen von Bradmer Pharmaceuticals Inc.